Outcome of Combined Temozolomide/CCNU versus Temozolomide (Standard or Extended) For Patients with Methylated MGMT Glioblastoma. Journal of Cancer Research Updates, [S. l.], v. 15, n. 3, p. 197–205, 2026. DOI: 10.30683/1929-2279.2026.15.18. Disponível em: https://mail.neoplasiaresearch.com/index.php/jcru/article/view/970. Acesso em: 16 jul. 2026.